Here’s why Pfizer is revising its revenue forecasts down

Last Updated: Dec. 16, 2025 at 9:26 a.m. ETFirst Published: Dec. 16, 2025 at 7:47 a.m. ET Pfizer…

17 dividend-stock bargains from a value manager with a stellar track record

Published: Dec. 2, 2025 at 12:11 p.m. ET The financial media’s coverage of markets and investing centers…

Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men

Memo also reportedly mentions vaccines for flu and pneumonia.

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Published: Nov. 18, 2025 at 4:21 p.m. ET Biopharma is back, and it’s smarter, slimmer and more…

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

Published: Nov. 10, 2025 at 8:05 a.m. ET Pfizer Inc. pulled off a comeback win, beating out…

Pfizer’s revenue falls as COVID sales and vaccine recommendations continue to fade

Last Updated: Nov. 4, 2025 at 9:49 a.m. ETFirst Published: Nov. 4, 2025 at 9:30 a.m. ET Shares…